Biogen Inc BIIB:NASDAQ

Last Price$197.78NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/23/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$192.00 (1)
Ask (Size)$198.68 (1)
Day Low / HighN/A - N/A
Volume1.4 M
 

View Biotechnology IndustryPeer Comparison as of 09/23/2022

 

Biogen Inc ( NASDAQ )

Price: $197.78
Change: -2.84 (1.42%)
Volume: 1.4 M
4:00PM ET 9/23/2022
 
 

Illumina Inc ( NASDAQ )

Price: $190.38
Change: -3.11 (1.61%)
Volume: 1.3 M
4:00PM ET 9/23/2022
 
 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $84.84
Change: -0.08 (0.09%)
Volume: 1.0 M
4:00PM ET 9/23/2022
 
 

Bio-Techne Corp ( NASDAQ )

Price: $291.06
Change: +0.84 (0.29%)
Volume: 246.7 K
4:00PM ET 9/23/2022
 
 

Moderna Inc ( NASDAQ )

Price: $123.64
Change: -0.68 (0.55%)
Volume: 3.9 M
4:00PM ET 9/23/2022
 

Read more news Recent News

Truist Securities Adjusts Biogen's Price Target to $265 from $270, Maintains Buy Rating
8:36AM ET 9/22/2022 MT Newswires

Biogen (BIIB) has an average rating of outperform and price targets ranging from $183 to $305, according to analysts polled by Capital IQ. (MT Newswires...

Boston Properties Acquires Laboratory, Life Sciences Property in Massachusetts From Biogen for $592 Million
7:21AM ET 9/20/2022 MT Newswires

Boston Properties (BXP) said Tuesday it completed the acquisition of 125 Broadway, a laboratory and life sciences property in Cambridge, Massachusetts,...

Stifel Nicolaus Lowers Biogen's Price Target to $223 From $230, Maintains Hold Rating
10:47AM ET 9/12/2022 MT Newswires

Biogen (BIIB) has an average rating of outperform and price targets ranging from $183 to $305, according to analysts polled by Capital IQ. (MT Newswires...

RBC Capital Cuts Price Target on Biogen to $251 From $259, Keeps Outperform Rating
8:41AM ET 9/02/2022 MT Newswires

Biogen (BIIB) has an average rating of outperform and price targets ranging from $183 to $305, according to analysts polled by Capital IQ. (MT Newswires...

View all Commentary and Analysis

The SEC Has Officially Cleared Cassava Sciences
8:00AM ET 9/22/2022 Seeking Alpha

The Biggest Pandemic Losers
11:50PM ET 9/19/2022 Seeking Alpha

Vertex Pharmaceuticals: Clinical Data Supports A Favorable Long-Term Growth Outlook
7:35PM ET 9/19/2022 Seeking Alpha

Tracking Southeastern Asset Management Portfolio - Q2 2022 Update
12:13AM ET 9/14/2022 Seeking Alpha

Company Profile

Business DescriptionBiogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. View company web site for more details
Address225 Binney Street
Cambridge, Massachusetts 02142
Phone+1.617.679.2000
Number of Employees7,800
Recent SEC Filing09/06/20224
Chief Executive Officer & DirectorMichel Vounatsos
EVP-Pharmaceutical Operations & TechnologyAlphonse Galdes
Chief Financial Officer & Executive Vice PresidentMichael R. McDonnell
Chief Medical Officer & Group Senior VPMahalakshmi Radhakrishnan

Company Highlights

Price Open$200.28
Previous Close$200.62
52 Week Range$187.16 - 299.83
Market Capitalization$28.7 B
Shares Outstanding145.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement10/19/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings14.11
Earnings per Share$19.04
Beta vs. S&P 500N/A
Revenue$12.1 B
Net Profit Margin20.57%
Return on Equity18.53%

Analyst Ratings as of 07/20/2022

Buy
14
Overweight
1
Hold
18
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset